Arthroscopic surgery combined with postoperative shock wave therapy for treating osteochondral lesions of the talus
- Conditions
- Osteochondral Lesions of the Talus, Hepple Phase ?-?Musculoskeletal Diseases
- Registration Number
- ISRCTN82244069
- Lead Sponsor
- Southwest Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 32
1. Age 18 years or more and less than 80 years (including 80 years)
2. The disease lasts for more than 6 months; symptoms still remain after drug treatment
3. MRI suggests the diagnosis of Hepple Phase-? Osteochondral Lesions of the Talus
4. The AOFAS score is lower than 75 after 10-12 weeks of ankle arthroscopy
5. Patients who sign the informed consent, agree to participant in the study and cooperate during the follow-up
1. Age less than 18 years or more than 80 years
2. MRI suggests Hepple Phase ? Osteochondral Lesions of the Talus associated with huge bone cyst
3. X-ray suggests malalignment of the lower limb or ankle joint (varus, valgus> 10 degrees)
4. Surgery history and shock wave treatment history of the ankle joint
5. Ankle OA, gout, local infection, coagulation abnormalities
6. Ankle ligamentous injury, or associated with other lesions that need surgical intervention
7. Pregnant women, deaf patients, or patients with mental disorders, etc., are excluded to ensure the accuracy of the follow-up
8. AOFAS scores of 10-12 weeks after ankle arthroscopy more than or equal to 75
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Function of the ankle joint is measured using the AOFAS scoring system at baseline, 6 weeks, 3, 6 and 12 months<br>2. Pain in the ankle joint is measured using the visual analogue scale at baseline, 6 weeks, 3, 6 and 12 months<br>3. Repair of the OLT is assessed using MRI scanning pre-operatively, and 3 and 12 months post-operatively
- Secondary Outcome Measures
Name Time Method 1. Patient death rate is assessed by reviewing medical notes at 12 months<br>2. Serious complications that require other treatment are assessed by participant interviews at 12 months